Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

Articles published in
Br J Surg
    August 2024
  1. PAOLUCCI I, Albuquerque Marques Silva J, Lin YM, Laimer G, et al
    Identification of A0 minimum ablative margins for colorectal liver metastases: multicentre, retrospective study using deformable CT registration and artificial intelligence-based autosegmentation.
    Br J Surg. 2024;111:znae165.
    >> Share

  2. SOREIDE K, Kok NFM
    Curative-intent ablation margins (A0) for colorectal liver metastasis: more burning questions.
    Br J Surg. 2024;111:znae184.
    >> Share

  3. ZUKAUSKAITE K, Horvath A, Gricius Z, Kvietkauskas M, et al
    Impact of mechanical bowel preparation on the gut microbiome of patients undergoing left-sided colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae213.
    >> Share

  4. OZCAN C, Colak T, Turkmenoglu O, Berkesoglu M, et al
    Impact of small-bite (5 mm) fascial closure on the incidence of incisional hernia following open colorectal cancer surgery: randomized clinical trial.
    Br J Surg. 2024;111:znae189.
    >> Share

  5. BOZKURT E, Sijberden JP, Langella S, Cipriani F, et al
    Laparoscopic versus open right hepatectomy for colorectal liver metastases after portal vein embolization: international multicentre study.
    Br J Surg. 2024;111:znae181.
    >> Share

  6. PEDRAZZANI C, Turri G, Ostuzzi G, Barbui C, et al
    Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae209.
    >> Share

  7. DONNELLY M, Ryan OK, Ryan EJ, Winter DC, et al
    Author response to: Comment on: Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2024;111:znae211.
    >> Share

    July 2024
  8. MARGONIS GA, Wang JJ, Boerner T, Moretto R, et al
    Hepatectomy versus systemic therapy for liver-limited BRAF V600E-mutated colorectal liver metastases: multicentre retrospective study.
    Br J Surg. 2024;111:znae176.
    >> Share

  9. JOYCE A, Drake TM, Hampson C, Monaghan A, et al
    Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae194.
    >> Share

  10. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Author response to: Comment on: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2024;111:znae193.
    >> Share

  11. GUAN X, Zhao X, Jiao S, Hao R, et al
    Circulating immune cell profile in patients with colorectal cancer.
    Br J Surg. 2024;111:znae186.
    >> Share

    June 2024
  12. BAO QR, Ferrari S, Capelli G, Chiloiro G, et al
    Oncological outcomes of patients not undergoing Total Mesorectal Excision after local excision: rethinking surgical indications.
    Br J Surg. 2024;111:znae144.
    >> Share

    May 2024
  13. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
    Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
    Br J Surg. 2024;111:znae070.
    >> Share

  14. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
    A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
    Br J Surg. 2024;111:znae110.
    >> Share

  15. GABRIELE R, Campagnol M, Iannone I, Sapienza P, et al
    Faecal occult blood and sigmoidoscopy data from the Italian national screening programme.
    Br J Surg. 2024;111:znae131.
    >> Share

    April 2024
  16. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
    Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
    Br J Surg. 2024;111:znae089.
    >> Share

    March 2024
  17. CUK P, Tiskus M, Moller S, Lambertsen KL, et al
    Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial.
    Br J Surg. 2024;111:znae049.
    >> Share

  18. GLYNNE-JONES R, Harrison M
    Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.
    Br J Surg. 2024;111:znad443.
    >> Share

  19. PEACOCK O
    Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
    Br J Surg. 2024;111:znad445.
    >> Share

  20. PEREA J, Garcia JL, Corchete LA, Marti M, et al
    Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
    Br J Surg. 2024;111:znae041.
    >> Share

  21. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
    Br J Surg. 2024;111:znae016.
    >> Share

    January 2024
  22. GOMEZ RUIZ M, Espin-Basany E, Spinelli A, Cagigas Fernandez C, et al
    Author response to: Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
    Br J Surg. 2024;111:znad444.
    >> Share

  23. KELM M, Flemming S
    Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST).
    Br J Surg. 2024;111:znad440.
    >> Share

  24. ALISEDA D, Arredondo J, Sanchez-Justicia C, Alvarellos A, et al
    Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
    Br J Surg. 2024;111:znae021.
    >> Share

  25. BROWN KGM, Solomon MJ, Sutton PA, Shin JS, et al
    The definition of clear resection margins in locally recurrent rectal cancer-time for consensus.
    Br J Surg. 2024;111:znad450.
    >> Share

  26. KRON P, Lodge JPA
    Changing perspectives in the treatment of colorectal liver metastases.
    Br J Surg. 2024;111:znad431.
    >> Share

  27. KUSTERS M
    Lateral pelvic lymph nodes in rectal cancer: a multi-disciplinary team effort is needed to prevent local recurrence.
    Br J Surg. 2024;111:znad449.
    >> Share

  28. TAYLOR AS, Au S, Krivankova B, Asanai K, et al
    Carbon footprint of laparoscopic right hemicolectomy.
    Br J Surg. 2024;111:znad422.
    >> Share

  29. SANO S, Fukunaga Y, Sakamoto T, Hiyoshi Y, et al
    Laparoscopic resection for locally advanced rectal cancer: propensity score-matched analysis.
    Br J Surg. 2024;111:znad350.
    >> Share

  30. AUSTIN KKS, Brown KGM, Solomon MJ
    En bloc lateral pelvic compartment excision during pelvic exenteration: video vignette.
    Br J Surg. 2024;111:znad407.
    >> Share

  31. DELATTRE F, Trilling B, Sage PY, Bonne A, et al
    Complete mesocolic excision for caecal tumours is overtreatment: COLOC study.
    Br J Surg. 2024;111:znad411.
    >> Share

  32. SADIEN ID
    Comment on: Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2024;111:znad399.
    >> Share

  33. SHIMOMURA M, Yoshinaka H, Egi H, Shimizu W, et al
    Author response to: Comment on: Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2024;111:znad400.
    >> Share

  34. WU Q, He Y, Wang Z
    Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2024;111:znad390.
    >> Share

  35. ZHANG W, Huang J
    Comment on: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2024;111:znad389.
    >> Share

  36. BRAUN M
    T3N1M0 rectal cancer: the optimal initial management is systemic anti-cancer therapy.
    Br J Surg. 2024;111:znad324.
    >> Share

  37. NILSSON PJ
    T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy.
    Br J Surg. 2024;111:znad322.
    >> Share

  38. ARTHUR C, Teo M
    T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy.
    Br J Surg. 2024;111:znad323.
    >> Share

  39. HARRIS DA
    T3 N1 M0 rectal cancer: optimal initial management is upfront surgery.
    Br J Surg. 2024;111:znad321.
    >> Share

  40. BONNE A, Trilling B, Sage PY, Fauconnier J, et al
    Influence of day of surgery on morbidity after laparoscopic colorectal resection for cancer in the era of enhanced recovery after surgery (ERAS).
    Br J Surg. 2024;111:znad387.
    >> Share

  41. STRIJKER D, Hoogeboom TJ, Meijerink JWJH, Taveirne A, et al
    Multimodal rehabilitation (Fit4Chemo) before and during adjuvant chemotherapy in patients with colonic cancer.
    Br J Surg. 2024;111:znad354.
    >> Share

  42. BILKHU AS, Wild J, Sagar PM
    Management of retrorectal tumours.
    Br J Surg. 2024;111:znae012.
    >> Share

    December 2023
  43. GRUTER AAJ, Toorenvliet BR, Belgers EHJ, Belt EJT, et al
    Nationwide standardization of minimally invasive right hemicolectomy for colon cancer and development and validation of a video-based competency assessment tool (the Right study).
    Br J Surg. 2023 Dec 16:znad404. doi: 10.1093.
    >> Share

  44. LYGRE KB, Eide GE, Liedenbaum MH, Augland IMB, et al
    Short and equal vascular stump length after standardized laparoscopic and open surgery with central lymphadenectomy for right-sided colon cancer.
    Br J Surg. 2023 Dec 8:znad410. doi: 10.1093.
    >> Share

    November 2023
  45. MIZUUCHI Y, Nagayoshi K, Nakamura M, Ikeuchi H, et al
    Prognostic impact of tumour location in stage II/III ulcerative colitis-associated colon cancer: subgroup analysis of a nationwide multicentre retrospective study in Japan.
    Br J Surg. 2023 Nov 25:znad386. doi: 10.1093.
    >> Share

  46. LEDERHUBER H, Massey LH, Abeysiri S, Roman MA, et al
    Preoperative intravenous iron and the risk of blood transfusion in colorectal cancer surgery: meta-analysis of randomized clinical trials.
    Br J Surg. 2023 Nov 23:znad320. doi: 10.1093.
    >> Share

  47. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2023 Nov 14:znad373. doi: 10.1093.
    >> Share

  48. ZHANG K, Yuan Z, Lu Y, Chen L, et al
    Totally robotic surgery for rectal cancer with the daVinci(R) single-port platform.
    Br J Surg. 2023;110:1890.
    >> Share

  49. GREIJDANUS NG, Wienholts K, Ubels S, Talboom K, et al
    Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients.
    Br J Surg. 2023;110:1863-1876.
    >> Share

  50. YOSHINAKA H, Shimomura M, Egi H, Shimizu W, et al
    Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2023;110:1769-1773.
    >> Share

  51. VIMALACHANDRAN D
    Neoadjuvant chemotherapy for locally advanced colonic cancer is not ready to be the standard of care.
    Br J Surg. 2023;110:1677-1678.
    >> Share

  52. MORTON D, Seligmann J
    Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.
    Br J Surg. 2023;110:1679-1680.
    >> Share

  53. VAUGHAN-SHAW PG, Evans MD
    Neoadjuvant chemotherapy for advanced colonic cancer: standard of care or is the jury still out?
    Br J Surg. 2023;110:1565-1566.
    >> Share

  54. KIYOZUMI Y, Yamaguchi T, Ichikawa N, Homma S, et al
    Endoscopic Surgical Skill Qualification System: propensity-score matched cohort analysis of accredited supervisors in laparoscopic rectal cancer surgery.
    Br J Surg. 2023;110:1834-1839.
    >> Share

  55. NORDKAMP S, van Rees JM, van den Berg K, Mens DM, et al
    Locally recurrent rectal cancer: oncological outcomes of neoadjuvant chemoradiotherapy with or without induction chemotherapy.
    Br J Surg. 2023;110:1637-1640.
    >> Share

  56. FRANCIS NK, Penna M, Dritsas S, Kinsey H, et al
    Oncological outcomes after transanal total mesorectal excision for rectal cancer.
    Br J Surg. 2023;110:1614-1617.
    >> Share

  57. GAO J, Gu X, Pang M, Zhang H, et al
    Risk factors for anastomotic leak and postoperative morbidity after right hemicolectomy for colon cancer: results from a prospective, multi-centre, snapshot study in China.
    Br J Surg. 2023 Nov 7:znad316. doi: 10.1093.
    >> Share

    October 2023
  58. JONES RP, Lee LYW, Corrie PG, Danson S, et al
    Individualized cancer vaccines versus surveillance after adjuvant chemotherapy for surgically resected high-risk stage 2 and stage 3 colorectal cancer: protocol for a randomized trial.
    Br J Surg. 2023 Oct 19:znad332. doi: 10.1093.
    >> Share

  59. YANG X, Hu Q
    Comment on: Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:1562.
    >> Share

  60. VAN EERDEN RAG, de Boer NL, van Kooten JP, Bakkers C, et al
    Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
    Br J Surg. 2023;110:1502-1510.
    >> Share

    September 2023
  61. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    >> Share

  62. HANY TS, Jadav AM, Parkin E, Bhowmick AK, et al
    Extraperitoneal approach to left-sided colorectal resections (EXPERTS procedure).
    Br J Surg. 2023;110:1348-1354.
    >> Share

  63. YANG X, Hu Q
    Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST).
    Br J Surg. 2023;110:1406.
    >> Share

  64. EMILE SH, Wexner SD
    Author response to: Comment on: Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:1405.
    >> Share

  65. JONES S, Perin G, Balasubramanian S
    Comment on: Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Br J Surg. 2023;110:1404.
    >> Share

  66. DONNELLY M, Ryan OK, Ryan EJ, Creavin B, et al
    Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2023;110:1316-1330.
    >> Share

  67. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    >> Share

  68. ARJONA-SANCHEZ A
    In favour of prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer.
    Br J Surg. 2023 Sep 2:znad279. doi: 10.1093.
    >> Share

  69. TANIS PJ
    Opposed to prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer.
    Br J Surg. 2023 Sep 2:znad280. doi: 10.1093.
    >> Share

    August 2023
  70. TEMMINK SJD, Peeters KCMJ, Renehan AG, Pares O, et al
    Author response to: Comment on: Outcomes following watch and wait of a clinical complete response in rectal cancer after neoadjuvant treatment: comparison of patients with and without complete response at first reassessment in the International Watch
    Br J Surg. 2023;110:1242.
    >> Share

  71. GOMEZ RUIZ M, Espin-Basany E, Spinelli A, Cagigas Fernandez C, et al
    Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
    Br J Surg. 2023;110:1153-1160.
    >> Share

  72. MEURETTE G, Faucheron JL, Cotte E, Denost Q, et al
    Low anterior resection syndrome after rectal resection management: multicentre randomized clinical trial of transanal irrigation with a dedicated device (cone catheter) versus conservative bowel management.
    Br J Surg. 2023;110:1092-1095.
    >> Share

  73. VAN REES JM, Krul MF, Kok NFM, Grunhagen DJ, et al
    Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies.
    Br J Surg. 2023;110:1049-1052.
    >> Share

    July 2023
  74. SHAH D, Di Re A, Toh JWT
    Aspirin chemoprevention in colorectal cancer: network meta-analysis of low, moderate, and high doses.
    Br J Surg. 2023 Jul 27:znad231. doi: 10.1093.
    >> Share

  75. BEETS GL
    Near-complete response following neoadjuvant therapy in rectal cancer: wait a bit longer?
    Br J Surg. 2023;110:938-939.
    >> Share

  76. MANENTI A, Caramaschi S, Farinetti A, Manco G, et al
    Comment on: Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:1018.
    >> Share

  77. PEREZ RO, Cerdan-Santacruz C, Sao Juliao GP
    Near-complete response following neoadjuvant therapy in rectal cancer: resect now?
    Br J Surg. 2023;110:936-937.
    >> Share

  78. GE Y, Zhang S, Zheng M, Zhang W, et al
    Comment on: Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:1017.
    >> Share

  79. NORDKAMP S, Piqeur F, van den Berg K, Tolenaar JL, et al
    Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.
    Br J Surg. 2023;110:950-957.
    >> Share

  80. PEACOCK O, Manisundaram N, Kim Y, Konishi T, et al
    Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything.
    Br J Surg. 2023;110:985-986.
    >> Share

  81. UUTELA A, Nordin A, Osterlund E, Halonen P, et al
    Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
    Br J Surg. 2023;110:931-935.
    >> Share

  82. SIRIWARDENA AK, Serrablo A, Fretland AA, Wigmore SJ, et al
    Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
    Br J Surg. 2023 Jul 14:znad124. doi: 10.1093.
    >> Share

    June 2023
  83. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:864-869.
    >> Share

  84. WU Q, Zhou J, Huang J, Deng X, et al
    Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2023;110:784-796.
    >> Share

  85. VERWEIJ ME, Franzen J, van Grevenstein WMU, Verkooijen HM, et al
    Timing of rectal cancer surgery after short-course radiotherapy: national database study.
    Br J Surg. 2023;110:839-845.
    >> Share

  86. GERRARD AD, Dunlop MG, Din FVN
    Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 Jun 1:znad121. doi: 10.1093.
    >> Share

    May 2023
  87. COHEN R, Platell CF, McCoy MJ, Meehan K, et al
    Circulating tumour DNA in colorectal cancer management.
    Br J Surg. 2023 May 16:znad126. doi: 10.1093.
    >> Share

  88. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    Robotic and laparoscopic colectomy: propensity score-matched outcomes from a national cancer database.
    Br J Surg. 2023;110:717-726.
    >> Share

  89. TEMMINK SJD, Peeters KCMJ, Bahadoer RR, Kranenbarg EM, et al
    Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Br J Surg. 2023;110:676-684.
    >> Share

  90. BERTELSEN CA, Bianchi PP, Croner R, Kleif J, et al
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:734.
    >> Share

  91. SO JBY
    Bi-directional chemotherapy for peritoneal metastases.
    Br J Surg. 2023;110:627-628.
    >> Share

  92. CHONG Y, Perin G, Balasubramanian SP
    Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 May 8:znad122. doi: 10.1093.
    >> Share

    April 2023
  93. DOHRN N, Klein MF
    Colorectal cancer: current management and future perspectives.
    Br J Surg. 2023 Apr 20:znad095. doi: 10.1093.
    >> Share

  94. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Author response to: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:621.
    >> Share

  95. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Author response to: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:617.
    >> Share

  96. AKYOL C, Kuzu MA
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:614.
    >> Share

    March 2023
  97. CRIPPS P, Scott K, Sekhar H, Harries RL, et al
    Faecal immunochemical testing in symptomatic lower gastrointestinal triage: cohort study of patient acceptability and impact of social deprivation.
    Br J Surg. 2023;110:511-512.
    >> Share

  98. WANG X
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:520.
    >> Share

  99. CASHIN PH, Soderstrom M, Blom K, Artursson S, et al
    Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.
    Br J Surg. 2023 Mar 15:znad066. doi: 10.1093.
    >> Share


  100. Erratum to: Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
    Br J Surg. 2023 Mar 4:znad072. doi: 10.1093.
    >> Share

    February 2023
  101. WENSINK GE, Bolhuis K, Elferink MAG, Fijneman RJA, et al
    Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases.
    Br J Surg. 2023;110:362-371.
    >> Share

  102. MATHEW A, Ramachandra D, Goyal A, Nariampalli Karthyarth M, et al
    Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:313-323.
    >> Share

  103. KITAGUCHI D, Hasegawa H, Teramura K, Ikeda K, et al
    Comparison of postoperative anorectal function between hand-sewn and stapled anastomoses in intersphincteric resection with transanal total mesorectal excision.
    Br J Surg. 2023;110:375-376.
    >> Share

  104. GERRARD AD, Maeda Y, Miller J, Gunn F, et al
    Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 Feb 14:znad016. doi: 10.1093.
    >> Share

  105. PEREA J, Winter D
    Early-onset sporadic colorectal cancer: key question of early diagnosis and screening strategies.
    Br J Surg. 2023 Feb 2:znad014. doi: 10.1093.
    >> Share

    January 2023
  106. EMILE SH, Horesh N, Freund MR, Garoufalia Z, et al
    Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:242-250.
    >> Share

  107. SERRA-ARACIL X, Mora-Lopez L
    Author response to: Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:284.
    >> Share

  108. ZHAO S, Tong W
    Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:283.
    >> Share

  109. SERRA-ARACIL X, Zarate A, Bargallo J, Gonzalez A, et al
    Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:150-158.
    >> Share

  110. REUVERS JRD, Budding AE, van Egmond M, Stockmann HBAC, et al
    Gut Proteobacteria levels and colorectal surgical infections: SELECT trial.
    Br J Surg. 2023;110:129-132.
    >> Share


  111. Erratum to: Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
    Br J Surg. 2023 Jan 4:znac459. doi: 10.1093.
    >> Share

    December 2022
  112. SHUKLA HS, Kumar S, Srivastava A
    Comment on: Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Dec 15:znac441. doi: 10.1093.
    >> Share

  113. ALEXANDRE C, Medhi K, Christelle F, Thierry A, et al
    Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
    Br J Surg. 2022 Dec 15:znac425. doi: 10.1093.
    >> Share

  114. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2022;110:98-105.
    >> Share

  115. CUSTERS PA, Geubels BM, Beets GL, Lambregts DMJ, et al
    Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review.
    Br J Surg. 2022;110:43-49.
    >> Share

  116. MAGHERBI H, Ouadi Y, Brahim MB, Boukriba S, et al
    Colonic lipoma.
    Br J Surg. 2022;110:122.
    >> Share

    November 2022
  117. STAIGER RD, Rossler F, Kim MJ, Brown C, et al
    Benchmarks in colorectal surgery: multinational study to define quality thresholds in high and low anterior resection.
    Br J Surg. 2022;109:1274-1281.
    >> Share

  118. CONEFREY C, Ochieng C, Hoffman C, Elliott D, et al
    Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
    Br J Surg. 2022 Nov 7. pii: 6806207. doi: 10.1093.
    >> Share


  119. Corrigendum to: Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Nov 3. pii: 6794309. doi: 10.1093.
    >> Share

    October 2022
  120. PANG K, Yang Y, Zhao P, Wu G, et al
    Adding immune checkpoint blockade to neoadjuvant chemoradiation in locally advanced rectal cancer.
    Br J Surg. 2022;109:1178-1179.
    >> Share

  121. BUETTNER S, Olthof PB, Wang J, Kreis ME, et al
    Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e122.
    >> Share

  122. LIU QL, Chen HN
    Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:e121.
    >> Share

  123. FAHIM M, Couwenberg A, Verweij ME, Dijksman LM, et al
    SPONGE-assisted versus Trendelenburg position surgery in laparoscopic sigmoid and rectal cancer surgery (SPONGE trial): randomized clinical trial.
    Br J Surg. 2022;109:1081-1086.
    >> Share

  124. BISSET CN, Ferguson E, MacDermid E, Stein SL, et al
    Exploring variation in surgical practice: does surgeon personality influence anastomotic decision-making?
    Br J Surg. 2022;109:1156-1163.
    >> Share

    September 2022
  125. LAMAZZA A, Fiori E, Carati M, Antoniozzi A, et al
    Endoscopic stenting for left-sided obstructing colorectal cancer.
    Br J Surg. 2022 Sep 27. pii: 6718181. doi: 10.1093.
    >> Share

  126. DACA-ALVAREZ M, Marti M, Spinelli A, de Miranda NFFC, et al
    Familial component of early-onset colorectal cancer: opportunity for prevention.
    Br J Surg. 2022 Sep 15. pii: 6701677. doi: 10.1093.
    >> Share

  127. FERNANDEZ B, Fleming CA, Marichez A, Mauriac P, et al
    Advances in pelvic exenteration surgery can support clear margin resection for metastatic non-pelvic primary malignancies.
    Br J Surg. 2022;109:1023-1024.
    >> Share

  128. DAY NM, Kearsey CC, Sutton PA
    Neoadjuvant treatment of advanced colonic cancer: a paradigm shift?
    Br J Surg. 2022;109:895-897.
    >> Share

  129. YEOW M, Soh S, Wong J, Koh FH, et al
    Transanal tube versus defunctioning stoma after low anterior resection for rectal cancer: network meta-analysis of randomized controlled trials.
    Br J Surg. 2022;109:900-903.
    >> Share

  130. KIYOZUMI Y, Akiyoshi T, Mukai T, Hiyoshi Y, et al
    Lateral local recurrence after total mesorectal excision for mid/low rectal cancer: study of clinical characteristics and impact of salvage surgery on survival.
    Br J Surg. 2022;109:904-907.
    >> Share

  131. MAROLI A, Carvello M, Foppa C, Kraft M, et al
    Anxiety as a risk factor for postoperative complications after colorectal surgery: new area for perioperative optimization.
    Br J Surg. 2022;109:898-899.
    >> Share

    August 2022
  132. KUNITOMO A, Ouchi A, Matsuo K, Komori K, et al
    Clinical significance of surgical intervention for isolated para-aortic lymph node metastasis from colorectal cancer: a time-varying co-variate analysis.
    Br J Surg. 2022 Aug 30. pii: 6678830. doi: 10.1093.
    >> Share


  133. Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial.
    Br J Surg. 2022 Aug 20. pii: 6672717. doi: 10.1093.
    >> Share

  134. ANDERSEN BT, Kazaryan AM, Stimec BV, Edwin B, et al
    Personalized surgery for the splenic flexure cancer: new frontiers.
    Br J Surg. 2022;109:880-881.
    >> Share

  135. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
    KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
    Br J Surg. 2022;109:804-807.
    >> Share


  136. Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Aug 8. pii: 6656065. doi: 10.1093.
    >> Share

    July 2022
  137. SIJBERDEN JP, Abu Hilal M
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Jul 16. pii: 6645296. doi: 10.1093.
    >> Share

  138. GEORGE AJ, Thomas C, Mathew DE, Jesudasan MR, et al
    Viral RNA in peritoneal, rectal, and blood samples from surgical patients with COVID-19.
    Br J Surg. 2022;109:772.
    >> Share

  139. FLEMING C, Vendrely V, Rullier E, Denost Q, et al
    Organ preservation in rectal cancer: review of contemporary management.
    Br J Surg. 2022;109:695-703.
    >> Share

  140. PODDA M, Pisanu A, Di Saverio S
    Author response to: Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg. 2022;109:e96.
    >> Share

  141. WANG X, Zheng Z, Xie Z, Huang S, et al
    Comment on: Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg. 2022;109:e95.
    >> Share

  142. MORISSON L, Verdonck O, Latulippe JF, Richebe P, et al
    Comment on: Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.
    Br J Surg. 2022;109:e93.
    >> Share

  143. FRANDON J, Berny L, Prudhomme M, de Forges H, et al
    Inferior mesenteric artery embolization ahead of rectal cancer surgery: AMIREMBOL pilot study.
    Br J Surg. 2022;109:650-652.
    >> Share

    June 2022

  144. Impact of microsatellite status in early-onset colonic cancer.
    Br J Surg. 2022;109:632-636.
    >> Share

  145. NORDKAMP S, Voogt ELK, van Zoggel DMGI, Martling A, et al
    Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral units.
    Br J Surg. 2022;109:623-631.
    >> Share

  146. ROSEN R, Nilsson E, Rahman M, Ronnow CF, et al
    Accuracy of MRI in early rectal cancer: national cohort study.
    Br J Surg. 2022;109:570-572.
    >> Share

    May 2022
  147. YAQUB S
    Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
    >> Share

  148. SIRIWARDENA AK
    Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
    Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
    >> Share

  149. BJORNELV GMW, Zolic-Karlsson Z, Dueland S, Line PD, et al
    Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases.
    Br J Surg. 2022;109:483-485.
    >> Share

  150. KOTHARI A, White MG, Peacock O, Kaur H, et al
    Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
    Br J Surg. 2022;109:489-492.
    >> Share

    April 2022
  151. VIGANO L, Terrone A, Costa G, Franchi E, et al
    Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases.
    Br J Surg. 2022;109:401-404.
    >> Share

  152. VAN DER HEIJDEN JAG, Qaderi SM, Verhoeven R, Custers JAE, et al
    Author response to: Transanal total mesorectal excision and low anterior resection syndrome.
    Br J Surg. 2022;109:e78.
    >> Share

  153. WALKER ET, McDermott FD, Smart NJ, Daniels IR, et al
    Comment on: Transanal total mesorectal excision and low anterior resection syndrome.
    Br J Surg. 2022;109:e77.
    >> Share

  154. KOTHARI A, White MG, Peacock O, Kaur H, et al
    Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
    Br J Surg. 2022 Apr 4. pii: 6562962. doi: 10.1093.
    >> Share

    March 2022
  155. SAW KS, Liu C, Xu W, Varghese C, et al
    Corrigendum to: Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
    Br J Surg. 2022 Mar 15. pii: 6548412. doi: 10.1093.
    >> Share

  156. PODDA M, Pisanu A, Morello A, Segalini E, et al
    Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
    Br J Surg. 2022;109:319-331.
    >> Share

  157. ZWANENBURG ES, Wisselink DD, Klaver CEL, Brandt ARM, et al
    Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial.
    Br J Surg. 2022;109:315-318.
    >> Share

  158. LOKUHETTY N, Mohan HM, Kong JC, Heriot AG, et al
    Lateral pelvic sidewall dissection in rectal cancer: case selection and training to optimize outcomes.
    Br J Surg. 2022;109:306-307.
    >> Share

    February 2022
  159. PATEL A, Spychalski P, Kobiela J
    Short-course radiotherapy and consolidation chemotherapy: in search of a balanced protocol.
    Br J Surg. 2022;109:e50-e51.
    >> Share


  160. Microsatellite instability in young patients with rectal cancer: molecular findings and treatment response.
    Br J Surg. 2022;109:251-255.
    >> Share

  161. SOREIDE K
    Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
    Br J Surg. 2022;109:242-243.
    >> Share

  162. CAMERON D, Talari A, Rehman I, Mitchell P, et al
    Detecting colorectal cancer using infrared spectroscopy.
    Br J Surg. 2022 Feb 10. pii: 6525757. doi: 10.1093.
    >> Share

  163. CRISTAUDO AT, Morris DL
    Hypothesis to explain the disparity in the proportion of liver metastases between appendiceal and colorectal cancer.
    Br J Surg. 2022 Feb 8. pii: 6524033. doi: 10.1093.
    >> Share

  164. SIRIWARDENA AK
    Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
    Br J Surg. 2022 Feb 3. pii: 6521658. doi: 10.1093.
    >> Share

  165. BRADLEY A, Knight S, Chin MY, Moug S, et al
    Comment on: Permanent stoma rates after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
    Br J Surg. 2022;109:e39.
    >> Share

  166. BACK E, Haggstrom J, Holmgren K, Haapamaki MM, et al
    Author response to: Permanent stoma prediction after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
    Br J Surg. 2022;109:e40.
    >> Share

  167. VAN DEN HEEDE K, Chidambaram S, Van Slycke S, Brusselaers N, et al
    Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
    Br J Surg. 2022;109:191-199.
    >> Share

    December 2021
  168. JUNG F, Lee M, Doshi S, Zhao G, et al
    Neoadjuvant therapy versus direct to surgery for T4 colon cancer: meta-analysis.
    Br J Surg. 2021;109:30-36.
    >> Share

  169. DENG X, Wu Q, Bi L, Yu Y, et al
    Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial.
    Br J Surg. 2021;109:121-128.
    >> Share

  170. BAHADOER RR, Peeters KCMJ, Beets GL, Figueiredo NL, et al
    Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
    Br J Surg. 2021;109:114-120.
    >> Share

  171. RAJARETNAM N, Smart NJ
    To mesh or not to mesh-the known unknowns of preventing parastomal hernias.
    Br J Surg. 2021;109:1-2.
    >> Share

  172. SAW KS, Liu C, Xu W, Varghese C, et al
    Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
    Br J Surg. 2021 Dec 15. pii: 6462011. doi: 10.1093.
    >> Share

  173. DUELAND S, Syversveen T, Hagness M, Grut H, et al
    Liver transplantation for advanced liver-only colorectal metastases.
    Br J Surg. 2021;108:1402-1405.
    >> Share

    November 2021
  174. POLSON R, Abdelqader B, Chung WY, Sangal S, et al
    Impact of the COVID-19 pandemic on early outcomes after colorectal cancer surgery.
    Br J Surg. 2021 Nov 11. pii: 6425606. doi: 10.1093.
    >> Share

  175. CLIFFORD RE, Harji D, Poynter L, Jackson R, et al
    Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study.
    Br J Surg. 2021;108:1270-1273.
    >> Share

  176. VAN HERWAARDEN YJ, Madani A, van der Post RS, Lemmens VEPP, et al
    Incidental diagnosis of serrated polyp in the appendix warrants colonoscopy to screen for colorectal neoplasia.
    Br J Surg. 2021;108:e373-e374.
    >> Share

  177. BACK E, Haggstrom J, Holmgren K, Haapamaki MM, et al
    Permanent stoma rates after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
    Br J Surg. 2021;108:1388-1395.
    >> Share

  178. HOL JC, Burghgraef TA, Rutgers MLW, Crolla RMPH, et al
    Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
    Br J Surg. 2021;108:1380-1387.
    >> Share

    October 2021
  179. KANANI A, Veen T, Soreide K
    Neoadjuvant immunotherapy in primary and metastatic colorectal cancer.
    Br J Surg. 2021 Oct 25. pii: 6409933. doi: 10.1093.
    >> Share

  180. PERDAWOOD SK, Neufert RS, Kroeigaard J, Maina PJ, et al
    Low presence of intraluminal cancer cells in rectal washout during transanal total mesorectal excision.
    Br J Surg. 2021;108:e338-e339.
    >> Share

  181. TIBERMACINE H, Rouanet P, Sbarra M, Forghani R, et al
    Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches.
    Br J Surg. 2021;108:1243-1250.
    >> Share

  182. HAAK HE, Beets GL, Peeters K, Nelemans PJ, et al
    Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
    Br J Surg. 2021;108:1251-1258.
    >> Share

  183. POLSON R, Abdelqadar B, Chung WY, Sangal S, et al
    Impact of the COVID-19 pandemic on early outcomes after colorectal cancer surgery.
    Br J Surg. 2021 Oct 21. pii: 6406949. doi: 10.1093.
    >> Share

  184. ISMAIEL M, Murphy B, Hayes C, O'Connell LV, et al
    Differential inflammatory profile of mesenteric and omental fat in patients with colorectal cancer.
    Br J Surg. 2021 Oct 6. pii: 6382002. doi: 10.1093.
    >> Share

  185. DIAMANTIS A, Samara AAlpha, Tzovaras G, Magouliotis D, et al
    Use of preoperative EORTC quality-of-life questionnaires to predict postoperative complications after colorectal cancer surgery.
    Br J Surg. 2021 Oct 3. pii: 6380642. doi: 10.1093.
    >> Share

    September 2021
  186. ASHRAF H, Anderson RG, Anderson DJ, Moug SJ, et al
    Feasibility of a perioperative smartphone application in colorectal surgery.
    Br J Surg. 2021;108:e282-e283.
    >> Share

  187. MORINO M, Forcignano E, Arezzo A
    Early clinical adoption of a flexible robotic endoscope for local excision of rectal lesions.
    Br J Surg. 2021;108:e296.
    >> Share

    August 2021
  188. SOLOMON MJ, Daster S, Loizides S, Sutton P, et al
    Access to the anterior pelvic compartment in pelvic exenteration in women-the interlabial approach: video vignette.
    Br J Surg. 2021;108:e268-e269.
    >> Share

  189. SUTTON PA, Solomon M, Sasidharan P, Lee P, et al
    Abdominolithotomy sacrectomy for the management of locally recurrent rectal cancer: video vignette.
    Br J Surg. 2021;108:e257.
    >> Share

  190. WALDRON RM, Moloney BM, Gilligan K, Lowery AJ, et al
    MicroRNAs as biomarkers of multimodal treatment for rectal cancer.
    Br J Surg. 2021;108:e260-e261.
    >> Share

  191. EL-WAJEH YAM, Askari G, Gordji ME, Mohammed-Ali RI, et al
    Elementary introduction to game theory, rationality and hyper-rationality decision-making: optimizing a surgeon's negotiation strategies.
    Br J Surg. 2021;108:e262-e263.
    >> Share

  192. VAN DER HEIJDEN JAG, Qaderi SM, Verhoeven R, Custers JAE, et al
    Transanal total mesorectal excision and low anterior resection syndrome.
    Br J Surg. 2021;108:991-997.
    >> Share

  193. KAWAGUCHI Y, Kopetz S, Tran Cao HS, Panettieri E, et al
    Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
    Br J Surg. 2021;108:968-975.
    >> Share

  194. LEE J, Grubac V, Baxter N, Auer R, et al
    Digital rectal examination in palpable rectal cancer: expert panel consensus on key elements and analysis of a case series.
    Br J Surg. 2021;108:e264-e265.
    >> Share

  195. CELARIER S, Monziols S, Celerier B, Assenat V, et al
    Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.
    Br J Surg. 2021;108:998-1005.
    >> Share

    July 2021
  196. ROXBURGH CS
    Organ preservation in rectal cancer: towards the norm rather than the exception.
    Br J Surg. 2021;108:745-747.
    >> Share

  197. DE LA MOTTE L, Custovic S, Tapper J, Arver S, et al
    Effect of preoperative radiotherapy for rectal cancer on spermatogenesis.
    Br J Surg. 2021;108:750-753.
    >> Share

  198. D'SOUZA N, Delisle TG, Chen M, Benton SC, et al
    Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study.
    Br J Surg. 2021;108:804-810.
    >> Share

  199. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
    Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Br J Surg. 2021;108:817-825.
    >> Share

    June 2021
  200. RYOO SB, Park JW, Lee DW, Lee MA, et al
    Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer.
    Br J Surg. 2021;108:644-651.
    >> Share

  201. DENOST Q, Rouanet P, Faucheron JL, Panis Y, et al
    Impact of early biochemical diagnosis of anastomotic leakage after rectal cancer surgery: long-term results from GRECCAR 5 trial.
    Br J Surg. 2021;108:605-608.
    >> Share

  202. TALBOOM K, Vogel I, Blok RD, Roodbeen SX, et al
    Highly selective diversion with proactive leakage management after low anterior resection for rectal cancer.
    Br J Surg. 2021;108:609-612.
    >> Share

  203. VOOGT ELK, Nordkamp S, Nieuwenhuijzen GAP, Creemers GJ, et al
    Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?
    Br J Surg. 2021;108:e213-e214.
    >> Share

    May 2021
  204. SEPPALA TT, Latchford A, Negoi I, Sampaio Soares A, et al
    European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.
    Br J Surg. 2021;108:484-498.
    >> Share

  205. GRAVERSEN M, Detlefsen S, Pfeiffer P, B Mortensen M, et al
    Local peritoneal toxicity from adjuvant pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in high-risk patients with colonic cancer.
    Br J Surg. 2021;108:e187-e188.
    >> Share

  206. CREAVIN B, Kelly ME, Ryan EJ, Ryan OK, et al
    Oncological outcomes of laparoscopic versus open rectal cancer resections: meta-analysis of randomized clinical trials.
    Br J Surg. 2021;108:469-476.
    >> Share

  207. CHAKRABARTI D, Rajan S, Akhtar N, Qayoom S, et al
    Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial.
    Br J Surg. 2021;108:511-520.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016